Logo image
New search Researchers Research units
Sign in
Transgender Women's Barriers, Facilitators, and Preferences on Tailored Injection Delivery Strategies to Administer Long-Acting Injectable Cabotegravir (CAB-LA) for HIV Pre-exposure Prophylaxis (PrEP)
Journal article   Open access   Peer reviewed

Transgender Women's Barriers, Facilitators, and Preferences on Tailored Injection Delivery Strategies to Administer Long-Acting Injectable Cabotegravir (CAB-LA) for HIV Pre-exposure Prophylaxis (PrEP)

Christine Tagliaferri Rael, Javier Lopez-Ríos, Stacey A McKenna, Doyel Das, Curtis Dolezal, Elena Abascal, Alex Carballo-Diéguez, Rebecca Schnall, Thomas J Hope, José Bauermeister, …
AIDS and behavior, v 25(12), pp 4180-4192
01 Dec 2021
PMID: 34216284
url
https://doi.org/10.1007/s10461-021-03357-yView
Published, Version of Record (VoR) Open

Abstract

Anti-HIV Agents - therapeutic use Female HIV Infections - drug therapy HIV Infections - prevention & control Humans Pre-Exposure Prophylaxis Pyridones Transgender Persons

Metrics

9 Record Views
20 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Public, Environmental & Occupational Health
Social Sciences, Biomedical
Logo image